等待開盤 09-09 09:30:00 美东时间
+0.030
+1.24%
Codexis, Inc. (NASDAQ: CDXS) announced its participation in the Cantor Global Healthcare Conference in New York from September 3-5, 2025. Management will engage in a fireside chat on September 4 at 3:55 pm ET, with a live webcast available on the Company’s Investor Relations website and a 90-day replay. Codexis leverages its proprietary CodeEvolver® technology to develop high-performance enzymes for efficient therapeutics manufacturing.
08-28 13:00
Codexis shares are trading higher after the company reported better-than-expect...
08-14 20:38
Earnings Call Insights: Codexis (CDXS) Q2 2025 Management View Stephen George Dilly, President, CEO & Chairman, stated the second quarter results were strong, highlighting that "our revenue is above c...
08-14 07:59
Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.34 percent. This is a 50 percent increase over losses of $(0.32) per share from the same
08-14 04:07
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Codexis (NASDAQ:CDXS) will release its quarterly earnings report on Wednesday, ...
08-13 05:01
Codexis, Inc. announced it will report its Q2 2025 financial results on August 13, 2025, after market close. A conference call and webcast discussing the results will be held at 4:30 pm Eastern Time. The live webcast will be available on Codexis' Investor Relations website, along with a 90-day archive. Call-in details are provided for domestic and international participants, including replay access. Codexis specializes in enzymatic solutions for ...
07-30 20:05
Codexis shares are trading lower after the company reported worse-than-expected...
05-15 23:46
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
Codexis (NASDAQ:CDXS) is gearing up to announce its quarterly earnings on Wedne...
05-14 05:03